Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Conditions
Ovarian Cancer · Platinum-sensitive Ovarian Cancer · PSOC
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mt. Sinai Comprehensive Cancer Center, Miami, Florida, United States
Sarasota Memorial Health Care System, Sarasota, Florida, United States
Miami Valley Hospital South, Centerville, Ohio, United States
Zangmeister Cancer Center, Columbus, Ohio, United States
National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan
Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan
Hyogo Cancer Center, Akashi, Hyōgo, Japan
Mie University Graduate School Of Medicine, Tsu, Mie-ken, Japan
Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, Japan
Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
The Jikei University Kashiwa Hospital, Kashiwa, Japan
Niigata University Medical & Dental Hospital, Niigata, Japan
Okayama University Hospital, Okayama, Japan
Kitasato University Hospital, Sagamihara, Japan
The Cancer Institute Hospital of JFCR, Tokyo, Japan
Kanagawa Prefectural Cancer Center, Yokohama, Japan
Study leads
Study Official
Study Director
Genmab